About this trial
Cesarean delivery is a commonly performed surgical procedure associated with worse postpartum pain when compared to vaginal birth. Uncontrolled postpartum pain is associated with increased neonatal and maternal risks. Multimodal non-opioid pain medications, including acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) are the preferred first-line therapies. There is no standard practice, however, on best dosing schedules (ie staggered or different time v. simultaneous or same time). This protocol describes a randomized clinical trial aimed to determine whether staggered dosing of acetaminophen and NSAIDs in superior to simultaneous dosing in controlling post-cesarean pain.
Eligibility criteria
Qualifiers
>/= 34 weeks gestation
Singleton pregnancy
Delivery via cesarean section under regional anesthesia
Disqualifiers
Contraindication to acetaminophen or NSAIDs
Current or history of opioid use or misuse
Intrauterine fetal demise
Major congenital anomaly
Trial design
Treatments tested in this trial
- Acetaminophen
- NSAID (Ketorolac/Ibuprofen)